FDA Investigator Ce'nedra M Martin
Ce'nedra M Martin has conducted inspections on 76 sites in 2 countries as of 21 Aug 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
76
Last Inspection Date:
21 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Bolivia (Plurinational State of)
FDA Investigators that have inspected at least one site in common with Ce'nedra M Martin:
Aaron J Poloni,
Abby M Miller,
Alan D Grupe,
Alexander M Kay,
Alicia Aborg Borm,
Amber M Howell,
Amy R Glynn,
Andrew K Haack, PhD,
Anh Trinh T Nguyen,
Anita Narula, PhD,
Avery J Dennis,
Bradley E Tufto,
Brenda K Alford,
Bruce R Burrell,
Camille Bennett Hoffman,
Catherine J Laufmann,
Celia L Hutchinstein,
Christina L Norton,
Christopher R Czajka,
Colleen M Jones,
Cynthia L Gorveatt,
Dam S Barkans,
Dan C Fisher,
David A Quale,
David J Gomes,
Dawn E Barkans,
Debra D Devlieger,
Dianna D Wardlow Dotter,
Dianne B Latona,
Dirk L Lincoln,
Dolores E Price,
Don A Brunssen,
Donald B Mckechnie,
Edward D Harris,
Elizabeth A Sheller,
Emanual A Kahsai,
Eric S Myskowski,
Farhana Khan,
Gavin W Pierce,
Gerard Pde Leon,
Gordon T Wales,
Hanna L Potter,
Harmon M Blanch,
Heika R Tait,
Hugh A Grimoldby,
Hughes,
Ian J Thomson,
Jacob N Hamilton,
James E Trabert,
James S Cartwright,
Jane M Kreis,
Jason T Lovelady,
Jean Brewer,
Jean C Colon Lopez,
Jeanne M Weishaar,
Jeff A Gard,
Jeffrey D Varelman,
Jeffrey J Leclair,
Jeffrey N Gerdes,
Jennifer W Cheng Dobson,
Jessica B Clark,
Jinkee Mvila Binayug,
John A Hall,
John E Emmert,
John W Banks,
Jonathan T Little,
Jose O Caraballo Rivera,
Kate L Allen,
Katharine Chan,
Katherine L Arnold,
Keegan B Mixon,
Keishla M Arroyo Lopez,
Kelsey M Bishop,
Kevin T Gerrity,
Kimberly Jproctor Jones,
Kristina M Phelps,
Lawrence Y Lee, PhD,
LCDR Ismael Olvera, IV,
Leon R Marquart,
Lesley A Swanson,
Lester O Boian,
Leya A Grosch,
Lisa A Bowden,
Marc A Jackson, Jr,
Marcus A Goshen,
Margo C Jones,
Mark E Imsland,
Mark E Moen,
Mark L Collins,
Mark W Babbitt,
Michael F Schuette,
Michael J Donovan,
Michael S Hudson,
Michael S Valenzuela,
Miguel Gmanzano Maldonado,
Mikel T Wright,
Nancy E Byerly,
Narahi J Alvarez Alcazar,
Ngoc Lan T Nguyen,
Paul M Kawamoto,
Peter Kessler, PhD,
Peter T Regan,
Rachelle M Deskins,
Rebecca A Sletner,
Rebecca T Davis,
Richard A Martin,
Rocco C Black,
Roger J Adams,
Ronald E Gill,
Sandra K Wangen,
Sangeeta M Khurana, PhD,
Sarah L Clark,
Shahriar Rahmani,
Sharon I Gundersen,
Shelagh D Schopen,
Stephanie J Shaw,
Stephen D Weagant,
Steven L Robbs,
Tara M Pianko,
Thomas C Mclean, CFS,
Timothy D Evans,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Vitaliy N Guyvan,
Wayne D Stowell,
Wilfred J Omoloh,
Willis L Hicks,
Xiaojun Yan
Ce'nedra M Martin's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2018 | FDA 483 | Chukar Cherry Company - Form 483, 2018-11-28 |
November, 2018 | FDA 483 Response | Chukar Cherry Company - Form 483R, 2018-12-19 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more